Clinical trial
Illuminating New Paths in the Treatment of Multiple Sclerosis Relapses - Early and Specialized Rehabilitation
NCT06956326 is registered in ClinicalTrials.gov with Lars Hvid as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Illuminating New Paths in the Treatment of Multiple Sclerosis Relapses - Early and Specialized Rehabilitation
- Lead sponsor
- Lars Hvid
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- May 1, 2025
- Completion date
- December 31, 2027
- Enrollment
- 64 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.